The Case Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1826-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.case.edu/cancer
Glioblastoma Remote Monitoring and Care - Research Protocol
- Conditions
- Venous ThromboembolismGlioblastomaSeizures
- Interventions
- Device: Apple Watch
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT06129760
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
- First Posted Date
- 2023-10-31
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Case Comprehensive Cancer Center
- Registration Number
- NCT06110598
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Development of MRF for Characterization of Brain Tumors After Radiotherapy
- Conditions
- Brain MetastasesBrain TumorBrain NecrosisGlioma
- Interventions
- Procedure: MRF in conjunction with IVIM MRI without contrast
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT06101069
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
- Conditions
- Pseudomyxoma PeritoneiSecondary Malignant Neoplasm of PeritoneumSecondary Malignant Neoplasm of Retroperitoneum
- Interventions
- Procedure: Intestinal, Multivisceral or Modified Multivisceral Transplantation
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT06084780
- Locations
- 🇺🇸
Cleveland Clinic Digestive Disease & Surgery Institute (DDSI), Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Topical aminolevulinate (10% ALA gel)Device: Red light illumination
- First Posted Date
- 2023-09-07
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT06027619
- Locations
- 🇺🇸
Cleveland Clinic, Dermatology and Plastic Surgery Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Individualized Treatments in Adults With Relapsed/Refractory Cancers
- Conditions
- Refractory CancerRelapsed Cancer
- Interventions
- Diagnostic Test: Drug Sensitivity Test (DST)
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT06024603
- Locations
- 🇺🇸
Florida International University, Miami, Florida, United States
🇺🇸Lerner College of Medicine, Cleveland Clinic Florida, Weston, Florida, United States
NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients
- Conditions
- Breast CancerProstate Cancer
- Interventions
- Behavioral: NAVAH
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05978232
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients
- Conditions
- Node-positive Breast Cancer
- Interventions
- Procedure: Axillary Lymph Node DissectionProcedure: Axillary Reverse MappingProcedure: Lymphaticovenous Bypass
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 400
- Registration Number
- NCT05970107
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
- Conditions
- Actinic Keratoses
- Interventions
- Drug: Topical AminolevulinateProcedure: Photodynamic therapy (PDT)Procedure: Red light illumination
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05923060
- Locations
- 🇺🇸
Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
- Conditions
- Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
- Interventions
- Other: Multiple Myeloma M-Protein AnalysisOther: Multiple Myeloma Knowledge Questionnaires
- First Posted Date
- 2023-04-26
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 201
- Registration Number
- NCT05831358
- Locations
- 🇺🇸
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio, United States